CVS Health Corp. buy Biotechhunter
Summary
This prediction ended on 31.07.20 with a price of €53.59. The price of CVS Health Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.85%. Dividends of €0.44 are taken into consideration when calculating the performance. Biotechhunter has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CVS Health Corp. | -0.234% | -0.234% | 36.102% | -17.870% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
Comments by Biotechhunter for this prediction
In the thread CVS Health Corp. diskutieren